Beyond the Scale: GLP-1 Receptor Agonists and the New Frontier of Cardio-Renal-Metabolic Medicine

How a single drug class is rewriting the treatment paradigm for heart failure, sleep apnea, and chronic kidney disease

Dr. Melvin Andrean
Post By

Dr. Melvin Andrean

The "Lazy Genius" of Bacteria: Unlocking the Molecular Pathways of Morbus Hansen (Leprosy)

A three-phase pathogenetic framework — from Trojan horse cellular entry and Schwann cell dedifferentiation to the immunological rheostat that determines the tuberculoid-lepromatous spectrum

dr. Aulia Rahmah
Post By

dr. Aulia Rahmah

  • March 2026

The Skin as a Battleground: A Structural and Cellular Pathology of Cutaneous Tuberculosis

From routes of bacterial entry to the tuberculous granuloma — understanding how Mycobacterium tuberculosis invades, colonizes, and destroys the skin

Arum Novia Ratri, MD
Post By

Arum Novia Ratri, MD

The Ten-Year Choice: Why Younger Heart Patients Are Rethinking TAVR and Returning to the Operating Table

How the durability limits of transcatheter bioprostheses, the complexity of valve-in-valve reintervention, and the expanding low-risk surgical evidence are reshaping aortic valve replacement decisions in patients under sixty

Orlensia Lie, MD
Post By

Orlensia Lie, MD

Go Back Top